brimonidine tartrate has been researched along with Allergic Contact Dermatitis in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (41.67) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 3 (25.00) | 2.80 |
Authors | Studies |
---|---|
Bourgault, S; Houle, MC; Lajoie, C; Ringuet, J; Simonyan, D | 1 |
Navarro-Triviño, FJ; Ruiz-Villaverde, R | 1 |
Castagliola, C; Fabbrocini, G; Napolitano, M; Patruno, C; Potestio, L | 1 |
Rajagopalan, A; Rajagopalan, B | 1 |
Cookson, H; McFadden, J; White, IR; White, J | 1 |
Bangsgaard, N; Fischer, LA; Zachariae, C | 1 |
Schmutz, JL | 1 |
Ratan, J; Sodhi, PK; Verma, L | 1 |
Bonini, S; Bucci, MG; Centofanti, M; Manni, G; Oddone, F; Parravano, M; Sacchetti, M | 1 |
Spaeth, GL | 1 |
Gross, RL; Orengo-Nania, S; Williams, GC | 1 |
Blondeau, P; Rousseau, JA | 1 |
12 other study(ies) available for brimonidine tartrate and Allergic Contact Dermatitis
Article | Year |
---|---|
The benefit of scratch patch testing to demonstrate ocular contact allergy to brimonidine tartrate.
Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Dermatitis, Allergic Contact; Humans; Patch Tests; Quinoxalines | 2022 |
Periocular allergic contact dermatitis caused by brinzolamide.
Topics: Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Dermatitis, Allergic Contact; Drug Combinations; Facial Dermatoses; Female; Glaucoma; Humans; Middle Aged; Ophthalmic Solutions; Sulfonamides; Thiazines | 2021 |
Allergic contact dermatitis probably due to brimonidine tartrate in eyedrops.
Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Dermatitis, Allergic Contact; Humans; Male; Ophthalmic Solutions | 2021 |
Allergic contact dermatitis to topical brimonidine.
Topics: Administration, Cutaneous; Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Dermatitis, Allergic Contact; Drug Eruptions; Erythema; Facial Dermatoses; Humans; Male; Middle Aged | 2015 |
Allergic contact dermatitis caused by Mirvaso®, brimonidine tartrate gel 0.33%, a new topical treatment for rosaceal erythema.
Topics: Administration, Cutaneous; Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Dermatitis, Allergic Contact; Dermatologic Agents; Facial Dermatoses; Female; Gels; Humans; Rosacea; Young Adult | 2015 |
Sensitization to and allergic contact dermatitis caused by Mirvaso(®) (brimonidine tartrate) for treatment of rosacea - 2 cases.
Topics: Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Dermatitis, Allergic Contact; Facial Dermatoses; Humans; Male; Middle Aged; Rosacea | 2016 |
[Allergic contact dermatitis to Mirvaso
Topics: Antihypertensive Agents; Brimonidine Tartrate; Dermatitis, Allergic Contact; Glucocorticoids; Humans; Male; Middle Aged; Treatment Outcome | 2017 |
Dermatological side effects of brimonidine: a report of three cases.
Topics: Administration, Topical; Adult; Aged; Antihypertensive Agents; Brimonidine Tartrate; Dermatitis, Allergic Contact; Diagnosis, Differential; Facial Dermatoses; Female; Glaucoma, Open-Angle; Humans; Lichen Planus; Male; Nail Diseases; Ocular Hypertension; Ophthalmic Solutions; Patch Tests; Quinoxalines | 2003 |
Demographic and clinical factors associated with development of brimonidine tartrate 0.2%-induced ocular allergy.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Conjunctivitis, Allergic; Demography; Dermatitis, Allergic Contact; Drug Hypersensitivity; Eyelid Diseases; Female; Glaucoma; Humans; Male; Middle Aged; Ophthalmic Solutions; Quinoxalines; Retrospective Studies; Risk Factors | 2004 |
Allergic contact dermatitis caused by topical eye drops.
Topics: Administration, Topical; Antihypertensive Agents; Blepharitis; Brimonidine Tartrate; Dermatitis, Allergic Contact; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Latanoprost; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines | 2006 |
Incidence of brimonidine allergy in patients previously allergic to apraclonidine.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Clonidine; Conjunctivitis; Cross Reactions; Dermatitis, Allergic Contact; Drug Hypersensitivity; Female; Glaucoma; Humans; Hyperemia; Incidence; Male; Middle Aged; Quinoxalines; Retrospective Studies; Risk Factors | 2000 |
Allergic reactions to brimonidine in patients treated for glaucoma.
Topics: Adrenergic alpha-Agonists; Aged; Antihypertensive Agents; Brimonidine Tartrate; Conjunctivitis, Allergic; Dermatitis, Allergic Contact; Drug Hypersensitivity; Female; Glaucoma; Humans; Levobunolol; Male; Quinoxalines; Retrospective Studies; Seasons | 2002 |